Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
Clinical trial NCT02633800 · TERMINATED
Trial details
- NCT number
- NCT02633800
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-22
- Primary completion
- 2018-01-11
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.